Pepwizard
Index · Guides · How to measure peptide outcomes

How to measure peptide outcomes

The minimum bloodwork, continuous-glucose, wearable, and training-log stack anyone on a peptide protocol should have in place. Companion to the "Everyone injects, no one measures" explainer. UK and US practical routes for each.

Updated 2026-04-22

Why this guide exists

Peptides are powerful enough to make the subjective story ("I feel sharper," "I'm recovering faster") feel true regardless of what the molecule is actually doing. Without a feedback loop, you can't distinguish a real effect from placebo, and you can't separate a benefit vector from a side-effect vector.

This guide is the practical companion to the "Everyone's injecting peptides, almost no one is measuring them" explainer. The explainer makes the case; this guide tells you exactly which test to order, from which service, at what cost.

It is not medical advice. It is a measurement framework. Discuss specific protocols with a qualified clinician.

The four measurement layers

A full outcome-measurement stack has four layers:

  1. Baseline bloodwork — before dose 1.
  2. Continuous glucose — a 14-day CGM window during the protocol.
  3. Autonomic and sleep wearables — 24/7, ideally starting 2 weeks before dose 1 to establish a baseline.
  4. Structured training and subjective logs — daily, throughout.

You can run the whole stack for roughly £300–500 per 8-week protocol in the UK, less in the US if you already have a wearable.

Layer 1 — baseline bloodwork

What to order

Absolute minimum for any peptide protocol:

  • Full blood count (FBC)
  • Liver function (LFTs)
  • Kidney function (U&Es)
  • Full lipid panel including ApoB and Lp(a)
  • Fasting glucose and insulin — calculate HOMA-IR
  • HbA1c
  • TSH, free T3, free T4
  • Morning cortisol
  • hsCRP

Additions by peptide class:

  • GH secretagogues (CJC-1295, sermorelin, tesamorelin, ipamorelin, MK-677): add IGF-1 (critical — this is the primary read-out).
  • GLP-1s (semaglutide, tirzepatide, retatrutide, orforglipron): add C-peptide, lipase, amylase.
  • BPC-157 / TB-500: the minimum panel is enough.
  • NAD+ precursors: add methylation panel (homocysteine, B12, folate) if dosing high.

Where to order (UK)

  • Medichecks — the most comprehensive at-home panel options. An "Advanced Well Man/Woman" plus IGF-1 add-on covers the minimum.
  • Thriva — simpler at-home finger-prick, useful for light-touch retesting.
  • Randox / London Medical Laboratory — more technically sophisticated if you want full CMP and hormone extensions.
  • Private GP — any Spire, HCA, or independent GP will order the panel. Cost is higher; you get a clinician letter with it.

Typical UK cost: £90–180 for the minimum panel, £140–260 with IGF-1 and C-peptide extensions.

Where to order (US)

  • Marek Health — peptide-aware, will also write prescriptions if needed.
  • Function Health — batched annual panel, consumer-friendly interface.
  • Quest Health / Labcorp OnDemand — direct-to-consumer, most affordable per-test.
  • Primary care physician — insurance typically covers the minimum if there's a documented reason.

Typical US direct-to-consumer cost: $150–350 for the minimum panel, higher with hormone extensions.

Layer 2 — continuous glucose

Any GH secretagogue, GLP-1, or insulin-affecting stack benefits from a 14-day CGM window during weeks 2–4 of the protocol. Two options:

  • Freestyle Libre 3 — at-home, no prescription required in most EU countries. In the UK, available direct-to-consumer from Abbott or via GP. Cost ~£60 per 14-day sensor.
  • Dexcom G7 — similar, marginally better accuracy, prescription-required in most jurisdictions.

What to watch:

  • Fasting glucose drift across the two weeks.
  • Post-meal excursions (peak glucose 60–90 minutes after carbs).
  • Overnight glucose (4 am glucose is often the cleanest endpoint).

A CGM during the protocol plus fasting glucose/insulin on the baseline panel catches the vast majority of metabolic side-effects from GH-secretagogue work before they show up on a repeat HbA1c.

Layer 3 — autonomic and sleep wearables

A wrist- or ring-worn wearable with a validated HRV signal running 24/7 gives you:

  • Resting heart rate trend (the earliest signal to move on any GLP-1)
  • HRV baseline and deviation (autonomic stress response)
  • Sleep architecture: deep sleep, REM, latency, efficiency

Validated options:

  • Oura Ring — best validated HRV and deep-sleep signal in the consumer segment.
  • Whoop — strong HRV, subscription model, heavier on subjective recovery framing.
  • Apple Watch + a strong third-party app (AutoSleep, Athlytic) — adequate if you already own one.
  • Garmin — strong for athletes, less granular sleep tracking than Oura.

What to do:

  1. Wear the device for at least 2 weeks before dose 1 to establish personal baseline ranges.
  2. Log dose days vs off days if the protocol isn't daily.
  3. Watch for 3+ day directional trends, not day-to-day noise.

Layer 4 — structured logs

The one thing no wearable or blood panel captures: subjective response and performance output.

A minimum log, daily, takes 60 seconds:

  • Bodyweight — first thing, same scale, same conditions.
  • Sleep hours + subjective quality (1–10).
  • Workout volume — set/rep/weight if lifting; distance/pace if running.
  • Energy and mood (1–10).
  • Dose (peptide, amount, timing).
  • Side effects (specific: nausea, HR spikes, joint water retention, appetite shifts).

A Notion template or a plain spreadsheet is enough. The point is that over 8 weeks you have a time series you can correlate against your bloodwork and wearable data.

Repeat cadence

For an 8-week protocol:

  • Week 0: full baseline bloods + 2 weeks of wearable baseline.
  • Week 2: start CGM. Stays on through week 4.
  • Week 4: mid-protocol bloods — IGF-1 + fasting glucose/insulin + any class-specific markers.
  • Week 8: full post-protocol bloods (same panel as week 0).

Weekly bloods at Bryan Johnson's cadence are achievable for self-funded adults but overkill for most first protocols. Every 4 weeks is a realistic floor.

The pre-protocol checklist

Before dose 1, answer these in writing:

  1. What specific outcome am I trying to produce? (body composition, recovery, sleep, metabolic — pick one primary)
  2. What biomarker or measurement will tell me whether it worked?
  3. What side-effect vector am I most at risk of, and how will I catch it early?
  4. What is my stop rule — the specific measurement change that would make me halt the protocol?

If you can't answer those four questions, don't start the protocol yet.

Where to go next